The Ras-ERK pathway modulates cytoskeleton organization, cell motility and lung metastasis signature genes in MDA-MB-231 LM2

Oncogene

Volumn 33, Issue 28, 2014, Pages 3668-3676

  Choi, C ^a   Helfman, D M ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

ERK; K Ras; lung metastasis signature; motility; PI3K; stress fiber

Indexed keywords

CXCL1 CHEMOKINE; INTERSTITIAL COLLAGENASE; K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOSIN LIGHT CHAIN KINASE; PAXILLIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSIENT RECEPTOR POTENTIAL CHANNEL M2; TROPOMYOSIN; UO 126; VINCULIN;

ACTIN FILAMENT; ARTICLE; CANCER CELL; CELL DISRUPTION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME PHOSPHORYLATION; FOCAL ADHESION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LUNG METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPINDLE CELL; STRESS FIBER; UPREGULATION; WOUND HEALING;

ACTINS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETON; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FOCAL ADHESIONS; GENES, NEOPLASM; HUMANS; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; RAS PROTEINS;

EID: 84904249412     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.341     Document Type: Article

References (34)

1. Olson MF, Sahai E. The actin cytoskeleton in cancer cell motility. Clin Exp Metasts 2009; 26: 273-287.
2. Pawlak G, Helfman DM. Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Genet Dev 2001; 11: 41-47. (Pubitemid 32119276)
3. Bakin AV, Safina A, Rinehart C, Daroqui C, Darbary H, Helfman DM. A critical role of tropomyosins in TGF-b regulation of the actin cytoskeleton and cell motility in epithelial cells. Mol Biol Cell 2004; 15: 4682-4694. (Pubitemid 39299114)
4. Janssen RAJ, Veenstra KG, Jonasch P, Jonasch E, Mier JW. Ras-and Raf-induced down-modulation of non-muscle tropomyosin are MEK-independent. J Biol Chem 1998; 273: 32182-32186. (Pubitemid 29177164)
5. Ljungdahl S, Linder S, Franzen B, Binetruy B, Auer G, Shoshan MC. Down-regulation of tropomyosin-2 expression in c-Jun-transformed rat fibroblasts involves induction of a MEK1-dependent autocrine loop. Cell GrowthDiffer 1998; 9: 565.
6. Prasad G, Masuelli L, Raj M, Harindranath N. Suppression of src-induced transformed phenotype by expression of tropomyosin-1. Oncogene 1999; 18: 2027.
7. Pawlak G, Helfman DM. Post-transcriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Rastransformed fibroblasts. Mol Biol Cell 2002; 13: 336-347. (Pubitemid 34106079)
8. Pritchard CA, Hayes L, Wojnowski L, Zimmer A, Marais RM, Norman JC. B-Raf acts via the ROCKII/LIMK/cofilin pathway to maintain actin stress fibers in fibroblasts. Mol Cell Biol 2004; 24: 5937-5952. (Pubitemid 38787977)
9. Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 2004; 18: 862-876. (Pubitemid 38529656)
10. Lee S, Helfman DM. Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway. J Biol Chem 2004; 279: 1885.
11. Makrodouli E, Oikonomou E, Koc M, Andera L, Sasazuki T, Shirasawa S et al. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study. Mol Cancer 2011; 10: 118.
12. Pollock CB, Shirasawa S, Sasazuki T, Kolch W, Dhillon AS. Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells. Cancer Res 2005; 65: 1244.
13. Wang XQ, Li H, Van Putten V, Winn RA, Heasley LE, Nemenoff RA. Oncogenic K-Ras regulates proliferation and cell junctions in lung epithelial cells through induction of cyclooxygenase-2 and activation of metalloproteinase-9. Mol Biol Cell 2009; 20: 791-800.
14. Sahai E, Olson MF, Marshall C. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. Sci Signal 2001; 20: 755.
15. Vial E, Sahai E, Marshall CJ. ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 2003; 4: 67-79. (Pubitemid 36904162)
16. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD et al. Genes that mediate breast cancer metastasis to lung. Nature 2005; 436: 518-524. (Pubitemid 41112921)
17. Barkan D, Kleinman H, Simmons JL, Asmussen H, Kamaraju AK, Hoenorhoff MJ et al. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 2008; 68: 6241.
18. Merlot S, Firtel RA. Leading the way: directional sensing through phosphatidylinositol 3-kinase and other signaling pathways. J Cell Sci 2003; 116: 3471-3478. (Pubitemid 37063391)
19. Bos PD, XH-F Zhang, Nadal C, Shu W, Gomis RR, Nguyen DX et al. Genes that mediate breast cancer metastasis to the brain. Nature 2009; 459: 1005-1009.
20. Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C et al. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 2007; 446: 765-770. (Pubitemid 46582040)
21. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451: 147-152.
22. Chen H, Zhu G, Li Y, Padia RN, Dong Z, Pan ZK et al. Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. Cancer Res 2009; 69: 9228-9235.
23. Stephens L, Ellson C, Hawkins P. Roles of PI3Ks in leukocyte chemotaxis and phagocytosis. Curr Opin Cell Biol 2002; 14: 203-213. (Pubitemid 34219510)
24. Ebi H, Corcoran RB, Singh A, Chen Z, Song Y, Lifshits E et al. Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers. J Clin Invest 2011; 121: 4311.
25. Turke AB, Song Y, Costa C, Cook R, Arteaga CL, Asara JM et al. MEK inhibition leads to PI3K/AKT activation by relieving a negative feedback on ERBB receptors. Cancer Res 2012; 72: 3228-3237.
26. Won JK, Yang HW, Shin SY, Lee JH, Heo WD, Cho KH. The crossregulation between ERK and PI3K signaling pathways determines the tumoricidal efficacy of MEK inhibitor. J Mol Cell Biol 2012; 4: 153-163.
27. Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 2004; 18: 862.
28. Larrea MD, Hong F, Wander SA, Da Silva TG, Helfman D, Lannigan D et al. RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility. Proc Natl Acad Sci 2009; 106: 9268.
29. Belguise K, Kersual N, Galtier F, Chalbos D. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 2004; 24: 1434-1444.
30. Hayashida T, Decaestecker M, Schnaper HW. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-b dependent responses in human mesangial cells. FASEB J 2003; 17: 1576-1578.
31. Tourkina E, Richard M, Gööz P, Bonner M, Pannu J, Harley R et al. Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 2008; 294: L843-L861.
32. Huntington JT, Shields JM, Der CJ, Wyatt CA, Benbow U, Slingluff Jr CL et al. Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells. J Biol Chem 2004; 279: 33168-33176.
33. Yamashita Y, Hishinuma M, Shimada M. Activation of PKA, p38 MAPK and ERK1/2 by gonadotropins in cumulus cells is critical for induction of EGF-like factor and TACE/ADAM17 gene expression during in vitro maturation of porcine COCs. J Ovarian Res 2009; 2: 20.
34. Eckert LB, Repasky GA, UlküAS, McFall A, Zhou H, Sartor CI et al. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis. Cancer Res 2004; 64: 4585-4592. (Pubitemid 38856932)